MedPath
FDA Approval

Senna

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Walgreens
DUNS: 008965063
Effective Date
May 7, 2025
Labeling Type
HUMAN OTC DRUG LABEL
Sennosides(8.6 mg in 1 1)

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Senna

Product Details

NDC Product Code
0363-8750
Application Number
M007
Marketing Category
OTC Monograph Drug (C200263)
Route of Administration
ORAL
Effective Date
May 7, 2025
Code: 3FYP5M0IJXClass: ACTIBQuantity: 8.6 mg in 1 1
CROSCARMELLOSE SODIUMInactive
Code: M28OL1HH48Class: IACT
DIBASIC CALCIUM PHOSPHATE DIHYDRATEInactive
Code: O7TSZ97GEPClass: IACT
HYPROMELLOSESInactive
Code: 3NXW29V3WOClass: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61UClass: IACT
MINERAL OILInactive
Code: T5L8T28FGPClass: IACT
© Copyright 2025. All Rights Reserved by MedPath